APAP 250 mg / Guaifenesin 1100 mg / Phenylephrine Hydrochloride 30 mg Extended Release Oral Tablet
RxNorm 616209
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 616209 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: APAP 250 mg / Guaifenesin 1100 mg / Phenylephrine Hydrochloride 30 mg Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Acetaminophen 250 mg / guaifenesin 1100 mg / phenylephrine hydrochloride 30 mg Extended Release Oral Tablet
(Atom ID: 12335191)
TMSY
Tall Man Lettering Synonym (TMSY):
Acetaminophen 250 mg / guaiFENesin 1100 mg / phenylephrine hydrochloride 30 mg Extended Release Oral Tablet
(Atom ID: 12378773)
SY
Synonym (SY):
APAP 250 mg / Guaifenesin 1100 mg / Phenylephrine Hydrochloride 30 mg Extended Release Oral Tablet
(Atom ID: 11817904)
TMSY